Biotech

All Articles

8 months after a $213M fundraise, gene editor Tome helps make decreases

.After increasing $213 thousand in 2023-- some of the year's largest private biotech shots-- Volume ...

BioMarin creates exec staff along with biotech vets-- Chutes &amp Ladders

.Accept to this week's Chutes &amp Ladders, our summary of considerable management hirings, firings ...

Biopharma Q2 VC attacked highest degree considering that '22, while M&ampA decreased

.Financial backing financing in to biopharma rose to $9.2 billion around 215 deals in the 2nd fourth...

Bicara, Zenas look for IPOs to press late-phase properties towards market

.Bicara Therapeutics and Zenas Biopharma have actually given new motivation to the IPO market along ...

Genentech to finalize cancer immunology research study department

.Genentech will close its cancer immunology analysis department, and system head and also prominent ...

Kezar goes down solid growth however to show its worth in phase 1 test

.Kezar Life Sciences is dropping its own unpromising stage 1 solid cyst medication as the biotech go...

Acelyrin drops izokibep, drops 3rd of team

.Despite izokibep keeping its own newfound winning streak in the clinic, Acelyrin is no more focusin...

Rivus' period 2 obesity-related cardiac arrest test attacks endpoint

.Rivus Pharmaceuticals has actually plumped up the leads of its own fat-busting, muscle-sparing drug...

Ovid standstills preclinical work, IV course after soticlestat neglect

.Ovid Therapy currently showed final month that it was trimming its own headcount as the provider na...

Eli Lilly opens up $700M nucleic acid R&ampD center in Boston ma Port

.Eli Lilly has actually opened a $700 thousand R&ampD facility in the Boston ma Seaport, improving i...